Web Results

Plerixafor

en.wikipedia.org/wiki/Plerixafor

Plerixafor is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients .... Jump up ^ "Mozobil approved for non-Hodgkin's lymphoma and multiple myeloma" (Press r...

Mozobil

www.mozobil.com/

Official site from Genzyme Corporation. Contains consumer and prescribing information.

FAQ's for Caregivers & Patients | Mozobil (plerixafor injection)

www.mozobil.com/patient/faq_for_caregivers_and_patients

See a list of commonly asked questions about treatment with Mozobil (plerixafor injection)

Mozobil (plerixafor) Uses, Dosage, Side Effects - Drugs.com

www.drugs.com/mozobil.html

Mozobil helps patients with non-Hodgkin's lymphoma by releasing stem cells that can be collected and transplanted back. Learn about side effects, interactions ...

Mozobil New FDA Drug Approval | CenterWatch

www.centerwatch.com/drug-information/fda-approved-drugs/drug/1009/mozobil-plerixafor-injection

Mozobil (plerixafor injection): For the treatment of non-Hodgkin's lymphoma and multiple myeloma. New approved drug details including side effects, uses and ...

Mozobil (plerixafor) injection label - U.S. Food and Drug Administration

www.accessdata.fda.gov/drugsatfda_docs/label/2010/022311s001lbl.pdf

MOZOBIL. MOZOBIL (plerixafor injection), Solution for Subcutaneous use ... Tumor Cell Mobilization in Leukemia Patients: Mozobil may mobilize leukemic cells ...

European Medicines Agency - Find medicine - Mozobil

www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001030/human_med_000910.jsp&mid=WC0b01ac058001d124

Next tab ». This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) ...

Mozobil 20 mg/ml solution for injection - Summary of Product ...

www.medicines.org.uk/emc/medicine/22187/SPC/Mozobil 20 mg ml solution for injection

Apr 1, 2015 ... Mozobil is indicated in combination with granulocyte-colony stimulating factor (G- CSF) to enhance mobilisation of haematopoietic stem cells to ...

FDA Approves Genzyme's Mozobil | Genzyme Corporation Online ...

news.genzyme.com/press-release/fda-approves-genzymes-mozobil

Dec 15, 2008 ...Mozobil is an important advancement in the treatment of patients with certain types of cancer who require a stem cell transplant,” said John F.

Mozobil : EPAR - European Medicines Agency - Europa.eu

www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001030/WC500030686.pdf

Mozobil 20 mg/ml solution for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. One ml of solution contains 20 mg plerixafor. Each vial contains  ...

More Info

Why Mozobil? | Mozobil (plerixafor injection)

www.mozobil.com

Mozobil (plerixafor injection) is approved by the United States Food and Drug Administration (FDA) to be used with another agent, granulocyte-colony ...

Mozobil (Plerixafor Injection) Drug Information: Description, User ...

www.rxlist.com

Mozobil (plerixafor injection) is a sterile, preservative-free, clear, colorless to pale yellow, isotonic solution for subcutaneous injection. Each mL of the sterile ...

Mozobil (Plerixafor Injection) Patient Information: Side Effects and ...

www.rxlist.com

Pictures of Mozobil (Plerixafor Injection), drug imprint information, side effects for the patient.